AstraZeneca Announces Pipeline Cuts, MedImmune Restructuring in 2018 Earnings
Glaxo adds flesh to its oncology ambitions
Experts Forecast Cancer Research and Treatment Advances in 2019
Science behind Nobel winners spawned one of the biggest marketing duels in pharma history
A timeline of key moments in the development of checkpoint inhibitors
James Allison Has Unfinished Business with Cancer
New Tool Added to the Cancer Immunotherapy Toolbox
Why Does Immunotherapy Cost So Much?